BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3939037)

  • 1. Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives.
    Elford HL; van't Riet B
    Pharmacol Ther; 1985; 29(2):239-54. PubMed ID: 3939037
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents.
    Elford HL; Van't Riet B; Wampler GL; Lin AL; Elford RM
    Adv Enzyme Regul; 1980; 19():151-68. PubMed ID: 6175187
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductase.
    Farr RA; Bey P; Sunkara PS; Lippert BJ
    J Med Chem; 1989 Aug; 32(8):1879-85. PubMed ID: 2666666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
    Cory JG; Sato A; Lasater L
    Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the mechanisms of inhibition of L1210 cell growth by 3,4-dihydroxybenzohydroxamic acid and 3,4-dihydroxybenzamidoxime.
    Tihan T; Elford HL; Cory JG
    Adv Enzyme Regul; 1991; 31():71-83. PubMed ID: 1877400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative analysis of steric and hydrophobic effects in ribonucleoside diphosphate reductase inhibition by thiosemicarbazones.
    Gupta SP; Prabhakar YS; Bindal MC; Handa A
    Arzneimittelforschung; 1984; 34(2):147-50. PubMed ID: 6372802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
    Moore EC; Hurlbert RB
    Pharmacol Ther; 1985; 27(2):167-96. PubMed ID: 3898152
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of ribonucleotide reductase activity and nucleic acid synthesis in tumor cells by the dialdehyde derivatives of inosine (NSC 118994) and inosinic acid.
    Cory JG; Mansell MM; Whitford TW
    Cancer Res; 1976 Sep; 36(9 pt.1):3166-70. PubMed ID: 987850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of herpes simplex virus ribonucleoside diphosphate reductase by derivatives of 2-acetylpyridine thiosemicarbazone.
    Turk SR; Shipman C; Drach JC
    Biochem Pharmacol; 1986 May; 35(9):1539-45. PubMed ID: 3011019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The active site of ribonucleoside diphosphate reductase.
    Thelander L; Hobbs J; Eckstein F
    Methods Enzymol; 1977; 46():321-7. PubMed ID: 909421
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase.
    Booth BA; Agrawal KC; Moore EC; Sartorelli AC
    Cancer Res; 1974 Jun; 34(6):1308-14. PubMed ID: 4363653
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nucleoside triphosphates on human ribonucleotide reductase from Molt-4F cells.
    Chang CH; Cheng YC
    Cancer Res; 1979 Dec; 39(12):5087-92. PubMed ID: 498136
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New ribonucleotide reductase inhibitors with antineoplastic activity.
    Elford HL; Wampler GL; van't Riet B
    Cancer Res; 1979 Mar; 39(3):844-51. PubMed ID: 427774
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-activity relationships among alpha-(N)-heterocyclic acyl thiosemicarbazones and related compounds as inhibitors of herpes simplex virus type 1-specified ribonucleoside diphosphate reductase.
    Turk SR; Shipman C; Drach JC
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1625-32. PubMed ID: 3016157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribonucleotide reductases: amazing and confusing.
    Stubbe J
    J Biol Chem; 1990 Apr; 265(10):5329-32. PubMed ID: 2180924
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of mammalian ribonucleotide reductase by a dinucleotide produced in eucaryotic cells.
    Lewis WH; McNaughton DR; Goh SH; LĂ©John HB; Wright JA
    J Cell Physiol; 1977 Dec; 93(3):345-52. PubMed ID: 338619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy directed at the components of nucleoside diphosphate reductase.
    Cory JG; Chiba P
    Pharmacol Ther; 1985; 29(1):111-27. PubMed ID: 3914643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantum-chemical studies on the mechanisms of inhibition of ribonucleotide reductase by aryl hydroxamic acids].
    Xu X; Luo YF; Cai WZ
    Yao Xue Xue Bao; 1993; 28(1):17-21. PubMed ID: 8328264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells.
    Meli M; Tolomeo M; Grifantini M; Mai A; Cappellacci L; Petrelli R; Rotili D; Ferro A; Saiko P; Szekeres T; Dusonchet L
    Int J Oncol; 2011 May; 38(5):1427-36. PubMed ID: 21318222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.